e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Molecular and clinical profile of adenocarcinoma lung among Indian women
P. Arjun (Trivandrum (Kerala), India)
Source:
International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Session:
Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Session type:
Thematic Poster
Number:
4260
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Arjun (Trivandrum (Kerala), India). Molecular and clinical profile of adenocarcinoma lung among Indian women. 4260
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Mutational status of advanced lung adenocarcinoma in a Portuguese cohort
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Molecular biomarkers for lung adenocarcinoma
Source: Eur Respir J , 49 (4) 1601734; DOI: 10.1183/13993003.01734-2016
Year: 2017
Comparative evaluation of survival time between women and men with advanced lung cancer
Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Year: 2008
Molecular epidemiology in non small cell lung cancer (NSCLC) tumors: implication of gender and histological features
Source: Eur Respir J 2006; 28: Suppl. 50, 335s
Year: 2006
Analysis of the clinical feature of 383 patients with lung cancer
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Molecular biologic characterization of operated non-small cell lung cancer according to smoking history
Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients
Year: 2008
Clinical evaluation of patients with lung carcinoma
Source: Eur Respir J 2002; 20: Suppl. 38, 437s
Year: 2002
Pathological profile of lung cancer in Tunisia
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012
Lung cancer in men compared with women: presentation, management, histologic characteristics and staging
Source: Eur Respir J 2003; 22: Suppl. 45, 249s
Year: 2003
Clinical, histological and molecular characteristics of lung cancer in patients under 30 years-old.
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Clinical feature of elderly patients with lung cancer
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013
Molecular abnormalities and histopathology in lung cancer
Source: ERS Research Seminar
Year: 2015
Molecular hallmarks of smoking in the Gauting lung adenocarcinoma donors
Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Year: 2020
Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
Correlation between dynamics of hystological spectrum of lung cancer diagnosed by bronchial biopsy and smoking curve in Romanian women in 10 years
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009
Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers
Source: Eur Respir J 2015; 45: 1403-1414
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept